SYDNEY, July 31, 2025 (GLOBE NEWSWIRE) — Axi, an industry-leading global broker, has been recognised with five awards* from the World Business Outlook Awards for 2025, marking a significant milestone in its continued growth and commitment to excellence: Best CFD Provider Australia Best Forex Trading Platform Australia Best 24/7 Customer
Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: Dr. Falk Pharma GmbH and Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. Announce Strategic Partnership to Develop a Novel AhR Agonist for the Treatment of Moderate to Severe Ulcerative Colitis Dr. Falk Pharma GmbH, a research-based pharmaceutical company specializing in digestive and
Ambiq Announces Pricing of Initial Public Offering AUSTIN, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Ambiq Micro, Inc. (“Ambiq”), a technology leader in ultra-low-power semiconductor solutions for edge AI, today announced the pricing of its upsized initial public offering of 4,000,000 shares of its common stock at a public offering
SAN FRANCISCO, July 29, 2025 (GLOBE NEWSWIRE) — Meltwater, a global leader in media, social, and consumer intelligence, today announces the launch of GenAI Lens, an industry-first, groundbreaking tool that gives companies unprecedented visibility into how their brand, competitors and industry are discussed across all major AI Assistants and LLMs
Transaction eliminates more than $1.3 billion of existing debt and secures $300 million of new senior financing, meaningfully strengthening Mavenir’s balance sheet. Mavenir well-positioned for sustained growth and long-term success. Siris remains controlling shareholder with support from key existing Mavenir lenders. RICHARDSON, Texas, July 29, 2025 (GLOBE NEWSWIRE) — Mavenir,
SYDNEY, July 29, 2025 (GLOBE NEWSWIRE) — Global broker Axi proudly announces a major milestone in its trader funding program, Axi Select, as it celebrates its 5th $1 million funded trader, and surpasses $5 million in profit payouts year-to-date. The latest trader to reach the $1 million mark is Yoleny
